Table 1.
Cohort | Viral suppression (VL <400 copies/mL | VL≥400 copies/mL | Viral suppression (VL <1000 copies/mL) | VL≥1000 copies/mL | |
No (%) VL tests all data | 1 985 883 (100) | 1 621 536 (81.7) | 364 343 (18.3) | 1 672 082 (84.2) | 313 797 (15.8) |
Male | 635 283 (32.0) | 508 025 (80.0) | 127 258 (20.0) | 524 270 (82.5) | 111 013 (17.5) |
Female | 1 350 600 (68.0) | 1 113 511 (82.4) | 237 085 (17.6) | 1 147 816 (85.0) | 202 784 (15.0) |
Med (IQR) age (years) | 35 (29–42) | 36 (30–43) | 34 (27–41) | 36 (30–43) | 34 (27–41) |
NHLS, National Health Laboratory Service; VL, viral load.